Chest

Journal

Publication Venue For

  • Association of Right Ventricular Afterload With Atrial Fibrillation Risk in Older Adults: The Atherosclerosis Risk in Communities Study.  162:884-893. 2022
  • Clinical Markers Associated with Risk of Suicide or Drug Overdose Among Heavy Smokers - A Longitudinal Follow-Up Study of the COPDGene Cohort. 2022
  • Cough-Specific Quality of Life Predicts Disease Progression Among Patients With Interstitial Lung Disease: Data From the Pulmonary Fibrosis Foundation Patient Registry.  162:603-613. 2022
  • Resuscitation Quality in the ICU: A Retrospective Analysis.  162:569-577. 2022
  • Provider Perspectives on and Access to Palliative Care for Patients With Interstitial Lung Disease.  162:375-384. 2022
  • Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease: A Multidisciplinary Delphi Study.  162:145-155. 2022
  • Bleeding Risk With Combination Intrapleural Fibrinolytic and Enzyme Therapy in Pleural Infection: An International, Multicenter, Retrospective Cohort Study. 2022
  • Response.  161:e398. 2022
  • Identification of Sputum Biomarkers Predictive of Pulmonary Exacerbations in COPD.  161:1239-1249. 2022
  • Primary Prophylaxis for Pneumocystis jirovecii Pneumonia in Patients Receiving Rituximab.  161:1201-1210. 2022
  • The Role of Palliative Care in COPD.  161:1250-1262. 2022
  • Longitudinal Association Between Muscle Loss and Mortality in Ever Smokers.  161:960-970. 2022
  • Significance of FEV3/FEV6 in Recognition of Early Airway Disease in Smokers at Risk of Development of COPD: Analysis of the SPIROMICS Cohort.  161:949-959. 2022
  • Bronchial Thermoplasty in Patients With Severe Asthma at 5 Years: The Post-FDA Approval Clinical Trial Evaluating Bronchial Thermoplasty in Severe Persistent Asthma Study.  161:614-628. 2022
  • Detection and Early Referral of Patients With Interstitial Lung Abnormalities: An Expert Survey Initiative.  161:470-482. 2022
  • Communicating About Time-Limited Trials.  161:202-207. 2022
  • A 37-Year-Old Man With Interstitial Lung Disease and Progressive Dyspnea..  160:e657-e660. 2021
  • Emphysema Progression and Lung Function Decline Among Angiotensin Converting Enzyme Inhibitors and Angiotensin-Receptor Blockade Users in the COPDGene Cohort.  160:1245-1254. 2021
  • Variation in Early Management Practices in Moderate-to-Severe ARDS in the United States: The Severe ARDS: Generating Evidence Study.  160:1304-1315. 2021
  • Identification of Distinct Clinical Subphenotypes in Critically Ill Patients With COVID-19.  160:929-943. 2021
  • The Association Between Lung Hyperinflation and Coronary Artery Disease in Smokers.  160:858-871. 2021
  • Pulmonary Arterial Pruning and Longitudinal Change in Percent Emphysema and Lung Function: The Genetic Epidemiology of COPD Study.  160:470-480. 2021
  • Identification and Remediation of Environmental Exposures in Patients With Interstitial Lung Disease: Evidence Review and Practical Considerations..  160:219-230. 2021
  • Ratio of FEV1/Slow Vital Capacity of < 0.7 Is Associated With Clinical, Functional, and Radiologic Features of Obstructive Lung Disease in Smokers With Preserved Lung Function.  160:94-103. 2021
  • Pleural Pressure Targeted Positive Airway Pressure Improves Cardiopulmonary Function in Spontaneously Breathing Patients With Obesity.  159:2373-2383. 2021
  • Essential Components of an Interstitial Lung Disease Clinic: Results From a Delphi Survey and Patient Focus Group Analysis.  159:1517-1530. 2021
  • Trends and Geographic Variation in Acute Respiratory Failure and ARDS Mortality in the United States.  159:1460-1472. 2021
  • Effect of Age on the Efficacy and Safety of Once-Daily Single-Inhaler Triple-Therapy Fluticasone Furoate/Umeclidinium/Vilanterol in Patients With COPD: A Post Hoc Analysis of the Informing the Pathway of COPD Treatment Trial.  159:985-995. 2021
  • A National Survey of Burnout and Depression Among Fellows Training in Pulmonary and Critical Care Medicine: A Special Report by the Association of Pulmonary and Critical Care Medicine Program Directors.  159:733-742. 2021
  • Clinical Phenotypes of Atopy and Asthma in COPD: A Meta-analysis of SPIROMICS and COPDGene.  158:2333-2345. 2020
  • Serum IgG Levels and Risk of COPD Hospitalization: A Pooled Meta-analysis.  158:1420-1430. 2020
  • WHERE'S HER PARENCHYMA? IDIOPATHIC GIANT BULLOUS EMPHYSEMA IN A YOUNG WOMAN.  158:a1163. 2020
  • Machine Learning and Prediction of All-Cause Mortality in COPD.  158:952-964. 2020
  • Association of Guideline-Recommended COPD Inhaler Regimens With Mortality, Respiratory Exacerbations, and Quality of Life: A Secondary Analysis of the Long-Term Oxygen Treatment Trial.  158:529-538. 2020
  • The “Good” Home Death in Pulmonary Disease: Avoiding the “Bad” and the “Ugly”.  158:449-450. 2020
  • Luminal Plugging on Chest CT Scan: Association With Lung Function, Quality of Life, and COPD Clinical Phenotypes.  158:121-130. 2020
  • Hospital-Based Resource Use and Costs Among Patients With Idiopathic Pulmonary Fibrosis Enrolled in the Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry.  157:1522-1530. 2020
  • Disease Severity and Quality of Life in Patients With Idiopathic Pulmonary Fibrosis: A Cross-Sectional Analysis of the IPF-PRO Registry.  157:1188-1198. 2020
  • POINT: Are Eosinophils Useful for the Management of COPD? Yes.  157:1073-1075. 2020
  • Rebuttal From Drs Wade and Wells.  157:1078-1079. 2020
  • Associations Among 25-Hydroxyvitamin D Levels, Lung Function, and Exacerbation Outcomes in COPD: An Analysis of the SPIROMICS Cohort.  157:856-865. 2020
  • Preoperative Evaluation of Patients With Interstitial Lung Disease.  156:826-833. 2019
  • AN UNUSUAL CASE OF DESQUAMATIVE INTERSTITIAL PNEUMONIA RECURRENCE AFTER LUNG TRANSPLANT.  156:a1233. 2019
  • The St. George's Respiratory Questionnaire Definition of Chronic Bronchitis May Be a Better Predictor of COPD Exacerbations Compared With the Classic Definition.  156:685-695. 2019
  • Clinical Epidemiology of COPD: Insights From 10 Years of the COPDGene Study.  156:228-238. 2019
  • Predictors of Response to Endobronchial Coil Therapy in Patients With Advanced Emphysema.  155:928-937. 2019
  • Systemic Markers of Inflammation in Smokers With Symptoms Despite Preserved Spirometry in SPIROMICS.  155:908-917. 2019
  • Lessons Learned From Web- and Social Media-Based Educational Initiatives by Pulmonary, Critical Care, and Sleep Societies.  155:671-679. 2019
  • Aspirin Use and Respiratory Morbidity in COPD: A Propensity Score-Matched Analysis in Subpopulations and Intermediate Outcome Measures in COPD Study.  155:519-527. 2019
  • Characteristics and Health-care Utilization History of Patients With Bronchiectasis in US Medicare Enrollees With Prescription Drug Plans, 2006 to 2014.  154:1311-1320. 2018
  • AN UNUSUAL CAUSE OF ENCEPHALOPATHY: STEROID RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS (SREAT).  154:383a-384a. 2018
  • Acute Tetrahydrobiopterin Improves Endothelial Function in Patients With COPD.  154:597-606. 2018
  • Visual Estimate of Coronary Artery Calcium Predicts Cardiovascular Disease in COPD.  154:579-587. 2018
  • Survival After an ICU Hospitalization for Pulmonary Hypertension.  154:229-231. 2018
  • Diaphragm Dysfunction in Critical Illness.  153:1040-1051. 2018
  • Survival of Lung Transplant Candidates With COPD: BODE Score Reconsidered.  153:697-701. 2018
  • Response.  153:568-569. 2018
  • Lobar Emphysema Distribution Is Associated With 5-Year Radiological Disease Progression.  153:65-76. 2018
  • Pharmacotherapy for Non-Cystic Fibrosis Bronchiectasis: Results From an NTM Info & Research Patient Survey and the Bronchiectasis and NTM Research Registry.  152:1120-1127. 2017
  • Response.  152:1351. 2017
  • Totally Implantable IV Treprostinil Therapy in Pulmonary Hypertension Assessment of the Implantation Procedure.  152:1128-1134. 2017
  • Response.  152:1092-1093. 2017
  • A Multicenter, Randomized Trial of Ramped Position vs Sniffing Position During Endotracheal Intubation of Critically Ill Adults.  152:712-722. 2017
  • Clinical Outcomes of Weight-Based Norepinephrine Dosing in Underweight and Morbidly Obese Patients.  152:a408. 2017
  • Hashimoto Encephalopathy: A Rare Autoimmune Encephalopathy Reversible With Steroid Therapy.  152:a360. 2017
  • Mauriac Syndrome: A Rare Cause of Lactic Acidosis in the ICU.  152:a422. 2017
  • Monitoring Activity Levels in ICU Survivors With Accelerometers.  152:a394. 2017
  • Norepinephrine Dosing in Obese Patients: Impact of Weight-Based Dosing on Short- and Long-Term Mortality.  152:a403. 2017
  • Pulmonary Inflammatory Pseudotumor and Skull Plasma Cell Granuloma as Metachronous Manifestations of IgG4-Related Disease.  152:a719. 2017
  • Lung Transplant Candidates on Extracorporeal Support.  151:1177-1178. 2017
  • Liberation From Mechanical Ventilation in Critically Ill Adults: An Official American College of Chest Physicians/American Thoracic Society Clinical Practice Guideline: Inspiratory Pressure Augmentation During Spontaneous Breathing Trials, Protocols Minimizing Sedation, and Noninvasive Ventilation Immediately After Extubation.  151:166-180. 2017
  • Liberation From Mechanical Ventilation in Critically Ill Adults: Executive Summary of an Official American College of Chest Physicians/American Thoracic Society Clinical Practice Guideline.  151:160-165. 2017
  • Obesity Is Associated With Increased Morbidity in Moderate to Severe COPD.  151:68-77. 2017
  • Risk Factors for In-Hospital Mortality in Smoke Inhalation-Associated Acute Lung Injury: Data From 68 United States Hospitals.  150:1260-1268. 2016
  • A Novel Spirometric Measure Identifies Mild COPD Unidentified by Standard Criteria.  150:1080-1090. 2016
  • Treprostinil Administered to Treat Pulmonary Arterial Hypertension Using a Fully Implantable Programmable Intravascular Delivery System: Results of the DelIVery for PAH Trial.  150:27-34. 2016
  • Pulmonary artery enlargement is associated with cardiac injury during severe exacerbations of COPD.  149:1197-1204. 2016
  • Transcriptional profiling of endobronchial ultrasound-guided lymph node samples aids diagnosis of mediastinal lymphadenopathy.  149:535-544. 2016
  • Neutrophil Chemoattractant Peptide Proline-Glycine-Proline Is Increased in Acute Respiratory Distress Syndrome.  148:180a. 2015
  • The Battle of Bleeding and Clotting: Novel Use of Intranasal Bevacizumab in a Patient With Hereditary Hemorrhagic Telangiectasia and Chronic Thromboembolic Pulmonary Hypertension.  148:978a-978b. 2015
  • The idiopathic pulmonary fibrosis clinical research network (IPFnet): Diagnostic and adjudication processes.  148:1034-1042. 2015
  • Executive Summary: Prevention of Acute Exacerbation of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline.  147:883-893. 2015
  • Prevention of Acute Exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline.  147:894-942. 2015
  • Improved clinical and radiographic outcomes after treatment with ivacaftor in a young adult with cystic fibrosis with the P67L CFTR mutation.  147:e79-e82. 2015
  • Comparing cost of indwelling pleural catheter vs talc pleurodesis for malignant pleural effusion.  146:991-1000. 2014
  • Disseminated Thrombosis: A Stormy Presentation of a Myeloproliferative Disorder.  146:298a. 2014
  • Metastatic Papillary Thyroid Carcinoma Presenting as Progressive Dyspnea From ILD.  146:412a. 2014
  • Prediction of acute respiratory disease in current and former smokers with and without COPD.  146:941-950. 2014
  • Breath analysis in pulmonary arterial hypertension..  145:551-558. 2014
  • A clinical score (RAPID) to identify those at risk for poor outcome at presentation in patients with pleural infection.  145:848-855. 2014
  • CT scan-measured pulmonary artery to aorta ratio and echocardiography for detecting pulmonary hypertension in severe COPD.  145:824-832. 2014
  • Prolonged extracorporeal membrane oxygenation use as a bridge to lung transplantation: It is time for a national registry.  145:184-185. 2014
  • A new approach to classification of disease severity and progression of COPD.  144:1179-1185. 2013
  • Acquired cystic fibrosis transmembrane conductance regulator dysfunction in the lower airways in COPD.  144:498-506. 2013
  • Educating the adolescent and young adult with cystic fibrosis about their reproductive risks and options.  143:580-581. 2013
  • Effect of emphysema on CT scan measures of airway dimensions in smokers.  143:687-693. 2013
  • Increased dietary sodium is related to severity of obstructive sleep apnea in patients with resistant hypertension and hyperaldosteronism.  143:978-983. 2013
  • Latent class analysis identifies distinct phenotypes of primary graft dysfunction after lung transplantation.  144:616-622. 2013
  • Reduced sodium transport with nasal administration of the prostasin inhibitor camostat in subjects with cystic fibrosis.  144:200-207. 2013
  • Understanding the relationship between sweat chloride and lung function in cystic fibrosis.  144:1418. 2013
  • United States critical illness and injury trials group.  143:808-813. 2013
  • 24/7 In-house intensivist coverage and fellowship education: A cross-sectional survey of academic medical centers in the United States.  141:959-966. 2012
  • ADRB2 polymorphisms and budesonide/formoterol responses in COPD.  142:320-328. 2012
  • Interpreting lung function data using 80% predicted and fixed thresholds identifies patients at increased risk of mortality.  141:73-80. 2012
  • Six-minute walk distance predictors, including CT scan measures, in the COPDGene cohort.  141:867-875. 2012
  • The relationship between pulmonary emphysema and kidney function in smokers.  142:655-662. 2012
  • The significance of elevated tumor markers among patients with idiopathic pulmonary fibrosis before and after lung transplantation.  141:1047-1054. 2012
  • Effect of single vs bilateral lung transplantation on plasma surfactant protein D levels in idiopathic pulmonary fibrosis.  140:489-496. 2011
  • Depression and functional status are strongly associated with dyspnea in interstitial lung disease.  139:609-616. 2011
  • Fleeting alveolar infiltrates and reversed halo sign in patients with breast cancer treated with tangential beam irradiation.  139:454-459. 2011
  • Elevated pulmonary artery pressure is a risk factor for primary graft dysfunction following lung transplantation for idiopathic pulmonary fibrosis.  139:782-787. 2011
  • Lung transplantation in coal workers pneumoconiosis.  140:1387-1388. 2011
  • Racial differences in quality of life in patients with COPD.  140:1169-1176. 2011
  • An international randomized multicenter comparison of nasal potential difference techniques.  138:919-928. 2010
  • A 30-year-old man with facial flushing and a mediastinal mass.  138:746-749. 2010
  • Determining the optimal pneumococcal vaccination strategy for adults: Is there a role for the pneumococcal conjugate vaccine?.  138:486-490. 2010
  • The COPD helplessness index A new tool to measure factors affecting patient self-management.  137:823-830. 2010
  • Latent TB infection treatment acceptance and completion in the United States and Canada.  137:401-409. 2010
  • Obesity-asthma association: Is it explained by systemic oxidant stress?.  136:1055-1062. 2009
  • Soluble P-selectin and the risk of primary graft dysfunction after lung transplantation.  136:237-244. 2009
  • The metabolic syndrome and pulmonary vascular disease.  136:3-4. 2009
  • A 65-year-old man with odynophagia and a lung mass.  135:876-879. 2009
  • Genetic and reproductive knowledge among adolescents and adults with cystic fibrosis.  133:1533. 2008
  • Pneumococcal vaccination for patients with COPD: Current practice and future directions.  133:767-774. 2008
  • Tako-tsubo cardiomyopathy: An insight into pathogenesis.  133:583. 2008
  • Treprostinil-based therapy in the treatment of moderate-to-severe pulmonary arterial hypertension.  134:139-145. 2008
  • Vomiting and diarrhea in a 51-year-old woman with splenectomy.  134:438-441. 2008
  • Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer.  132:185-192. 2007
  • Gender differences in the severity of CT emphysema in COPD.  132:464-470. 2007
  • Is pulmonary arterial hypertension in neurofibromatosis type 1 secondary to a plexogenic arteriopathy?.  132:798-808. 2007
  • Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension.  131:453-459. 2007
  • Pulmonary impairment after tuberculosis.  131:1817-1824. 2007
  • Right ventricular pressure waveform and wave reflection analysis in patients with pulmonary arterial hypertension.  132:37-43. 2007
  • Risk indexes for exacerbations due to COPD: Need to validate using broader criteria [3].  132:735. 2007
  • Shifting the goalpost to stay younger: Normal spirometry but short of breath! [8].  131:1990. 2007
  • Using the St. George Respiratory Questionnaire to ascertain health quality in persons with treated pulmonary tuberculosis.  132:1591-1598. 2007
  • Efficacy of bosentan in a small cohort of adult patients with pulmonary arterial hypertension related to congenital heart disease.  129:1009-1015. 2006
  • Routine mediastinoscopy and esophageal ultrasound fine-needle aspiration in patients with non-small cell lung cancer who are clinically N2 negative: A prospective study.  130:1791-1795. 2006
  • Teach a man to fish and you have fed him for a lifetime.  129:220-221. 2006
  • Women with pathologic stage I, II, and III non-small cell lung cancer have better survival than men.  130:1796-1802. 2006
  • Delay in diagnosis of alpha1-antitrypsin deficiency: a continuing problem..  128:1989-1994. 2005
  • Extracellular adenosine triphosphate: A potential regulator of vasa vasorum neovascularization in hypoxia-induced pulmonary vascular remodeling.  128:608S-610S. 2005
  • Severe acute respiratory syndrome, pulmonary function tests, and quality of life: Lessons learned.  128:1088-1089. 2005
  • The low-voltage-activated calcium channel CAV3.1 controls proliferation of human pulmonary artery myocytes.  128:581S-582S. 2005
  • The management of chest tubes in patients with a pneumothorax and an air leak after pulmonary resection.  128:816-820. 2005
  • Bowel ischemia complicating pneumococcal pneumonia.  126:968s-1-968s-2. 2004
  • Fast tracking after ivor lewis esophagogastrectomy.  126:1187-1194. 2004
  • Functional assessment of pulmonary vein stenosis using radionuclide ventilation/perfusion imaging.  126:645-651. 2004
  • Respiratory syncytial virus causes increased bronchial epithelial permeability.  126:186-191. 2004
  • Talc pleurodesis: Basic fibroblast growth factor mediates pleural fibrosis.  126:1522-1528. 2004
  • Video-assisted thoracoscopic surgery using single-lumen endotracheal tube anesthesia.  126:281-285. 2004
  • Which exercise test should be used for patients with symptomatic COPD?.  126:668-670. 2004
  • Defensive role of pleural mesothelial cell sialomucins in tumor metastasis.  124:682-687. 2003
  • Lack of long-term adverse adrenal effects from inhaled triamcinolone: Lung Health Study II.  124:57-62. 2003
  • The effect of house dust mite aeroallergen and air pollutant exposures during infancy..  123:434S. 2003
  • The 6-min walk test: A quick measure of functional status in elderly adults.  123:387-398. 2003
  • A Mycotic Pulmonary Artery Aneurysm Presenting as an Endobronchial Mass.  124:1610-1612. 2003
  • Nuclear accumulation of p53 is a potential marker for the development of squamous cell lung cancer in smokers.  123:181-186. 2003
  • Pyrazinamide and rifampin vs isoniazid for the treatment of latent tuberculosis: Improved completion rates but more hepatotoxicity.  123:102-106. 2003
  • Tobacco dependence: a chronic disease..  121:686-687. 2002
  • Effects of training with heliox and noninvasive positive pressure ventilation on exercise ability in patients with severe COPD.  122:464-472. 2002
  • Enhancement of adenovirus-mediated gene transfer in lungs and epithelial cells by EGTA.  121:35S. 2002
  • Fatal work-related inhalation of harmful substances in the United States.  121:969-975. 2002
  • Oral corticosteroids increase esophageal acid contact times in patients with stable asthma.  121:625-634. 2002
  • Tobacco dependence: A chronic disease.  121:686-687. 2002
  • Work-related inhalation injuries [2] (multiple letters).  122:1865-1866. 2002
  • A 53-year-old man with hemoptysis.  120:298-301. 2001
  • Value of Mycobacterium tuberculosis fingerprinting as a tool in a rural state surveillance program.  120:1877-1882. 2001
  • The pregnancy that never was - Beta human chorionic gonadotropin secreting primary lung cancer.  118. 2000
  • Cardiac rhythm disturbances in the obstructive sleep apnea syndrome: Effects of nasal continuous positive airway pressure therapy.  118:591-595. 2000
  • Pulmonary hypertension causing pulmonary artery aneurysm.  116. 1999
  • Choosing the appropriate control [2] (multiple letters).  115:1214-1215. 1999
  • Pulmonary malacoplakia associated with Rhodococcus equi infection in a patient with AIDS.  115:889-892. 1999
  • Strategies in preserving lung health and preventing COPD and associated diseases: National Lung Health Education Program (NLHEP).  113. 1998
  • Clinical events detected during pulmonary rehabilitation: Using the ATS staging system as a measure of risk.  114. 1998
  • Mycobacterium tuberculosis presenting as immune mediated thrombocytopenia purpura.  114. 1998
  • Can chest CT decrease the use of preoperative bronchoscopy in the evaluation of suspected bronchogenic carcinoma?.  113:1244-1249. 1998
  • Intrapulmonary shunting in primary pulmonary hypertension: An observation in two patients treated with epoprostenol sodium.  114:334-336. 1998
  • Low serum antimycobacterial drug levels in non-HIV-infected tuberculosis patients.  113:1178-1183. 1998
  • A trial of antioxidants N-acetylcysteine and procysteine in ARDS. The Antioxidant in ARDS Study Group..  112:164-172. 1997
  • A trial of antioxidants N-acetylcysteine and procysteine in ARDS.  112:164-172. 1997
  • Airway deposition and clearance and systemic pharmacokinetics of amiloride following aerosolization with an ultrasonic nebulizer to normal airways.  112:1283-1290. 1997
  • Immediate transcatheter embolization of Swan-Ganz catheter-induced pulmonary artery pseudoaneurysm.  111:1450-1452. 1997
  • Massive pleural effusion in diffuse granulomatous disease.  112:284-288. 1997
  • Pulmonary capillaritis and alveolar hemorrhage. Update on diagnosis and management..  110:1305-1316. 1996
  • Brief vs. extended asthma self-management education.  110. 1996
  • Angiogenesis in mesotheliomas. Role of mesothelial cell derived IL-8..  109:21S-22S. 1996
  • Accepting the 'guideline' challenge.  110:1379-1381. 1996
  • Safety of nicotine polacrilex gum used by 3,094 participants in the Lung Health Study.  109:438-445. 1996
  • Gastroesophageal reflux-induced bronchoconstriction is microaspiration a factor?.  108:1220-1227. 1995
  • Invasive diagnostic methods for nosocomial pneumonia: Revisiting the folklore.  108:1492-1494. 1995
  • Reflex sympathetic dystrophy following arterial blood gas sampling in the intensive care setting.  108:578-580. 1995
  • Testing the waters: Differentiating transudates from exudates.  108:1191-1192. 1995
  • Gastroesophageal reflux-induced bronchoconstriction: An intraesophageal acid infusion study using state-of-the-art technology.  106:731-737. 1994
  • More on asthma prevention [7].  105:1906. 1994
  • Occupational exposure to tuberculosis: Risk and consequences.  106:658-659. 1994
  • Three-dimensional reconstruction of ultrafast chest CT for diagnosis and operative planning in a child with right pneumonectomy syndrome.  106:973-974. 1994
  • Transesophageal imaging in Cor triatriatum.  105:332-333. 1994
  • Functional and phenotypic properties of the CD4+ T cell population in a murine pulmonary delayed-type hypersensitivity response..  103:138S. 1993
  • A catastrophe is brewing.  103:332-334. 1993
  • A computer-controlled ventilator weaning system: A clinical trial.  103:1220-1226. 1993
  • Asthma prevention [3].  104:325-326. 1993
  • Fluid bronchogram: A common finding in opacified lung requiring contrast medium administration for demonstration.  104:960-962. 1993
  • Pleural effusion in patients with systemic cholesterol embolization.  103:792-795. 1993
  • Pulmonary atelectasis and dysphagia in a 69-year-old cachectic man.  103:917-919. 1993
  • Unilateral absence of a pulmonary artery; Data from cardiopulmonary exercise testing.  103:293-295. 1993
  • Asthma prevention. Task Force on Research and Education for the Prevention and Control of Respiratory Diseases..  102:216S-231S. 1992
  • Asthma prevention.  102:216S-231S. 1992
  • Bronchiolitis obliterans organizing pneumonia associated with systemic lupus erythematosus.  102:1171-1174. 1992
  • Bronchoscopy in North America; The ACCP survey [13].  102:1638-1640. 1992
  • Diverse roentgenographic manifestations of the rare pulmonary involvement in myeloma.  102:946-948. 1992
  • Nontuberculous mycobacteria in adult patients with cystic fibrosis.  102:70-75. 1992
  • Pulmonary barotrauma in mechanical ventilation; Patterns and risk factors.  102:568-572. 1992
  • Utilization of acute bronchodilator responses in stable COPD to predict the relative efficacy of individual agents.  101:1552-1557. 1992
  • A computer-controlled ventilator weaning system.  100:1096-1099. 1991
  • Apical Pneumocystis carinii pneumonia in AIDS patients not receiving inhaled pentamidine prophylaxis.  100:1462-1464. 1991
  • Long-term oxygen therapy.  100:544-549. 1991
  • Medication adherence patterns in chronic obstructive pulmonary disease.  99:837-841. 1991
  • Snoring (I): Daytime sleepiness in regular heavy snorers.  99:40-48. 1991
  • Unusual initial calcification of primary and metastatic seminomas; Detection by computed tomography.  99:1543-1545. 1991
  • Characteristics and correlates of asthma in a university clinic population.  98:821-828. 1990
  • High frequency jet ventilation and intermittent positive pressure ventilation. Effect of cerebral blood flow in patients after open heart surgery.  97:420-424. 1990
  • Prostacyclin but not phentolamine increases oxygen consumption and skin microvascular blood flow in patients with sepsis and respiratory failure.  98:1467-1472. 1990
  • Use of Doppler echocardiography and amyl nitrite inhalation to characterize left ventricular outflow obstruction in hypertrophic cardiomyopathy.  97:389-395. 1990
  • When does bronchial arterial embolization fail to control hemoptysis?.  97:515-516. 1990
  • Cardiovascular effects of high-frequency oscillatory and jet ventilation.  96:1400-1404. 1989
  • Computed tomographic detection of cavitary lung lesion complicating use of flow-directed ballon-tipped catheter.  96:432-434. 1989
  • Cystic fibrosis tracheobronchial effluent stimulates proliferation of lung fibroblasts in vitro.  95:234S-236S. 1989
  • Does intraeosphageal acid trigger bronchial asthma? No, but maybe yes!.  96:963-964. 1989
  • Left ventricular dysfunction in symptomatic mitral valve prolapse.  95:370-373. 1989
  • Mechanisms of pleural fibrosis in empyema. Pleural macrophage-mediated inhibition of fibroblast proliferation.  95. 1989
  • Selection of patients with acute pulmonary embolism for thrombolytic therapy. Thrombolysis in pulmonary embolism (TIPE) patient survey.  95:279S-281S. 1989
  • Aspiration resulting from gastroesophageal reflux; a cause of chronic bronchopulmonary disease.  93:676-677. 1988
  • Transbronchial biopsy without fluoroscopy. A seven-year perspective.  94:557-560. 1988
  • Treatment of histoplasmosis and blastomycosis.  93:848-851. 1988
  • Antiviral therapy and pulmonary disease.  91:246-251. 1987
  • Biologic and biochemical characterization of a macrophage-derived growth factor for rat lung fibroblasts.  91:15s-16s. 1987
  • Bochdalek hernia of diaphgram in the adult: Diagnosis by computed tomography.  92:1098-1101. 1987
  • Inverse ratio ventilation. PEEP in disguise?.  92:390-392. 1987
  • Nasal continuous positive airway pressure in atelectasis.  92:621-624. 1987
  • Regulation of differentiation of airway epithelial cells.  91:22s-23s. 1987
  • Relationship of the ventilatory response to cotton bract extract and the cells and proteins of the lung.  91:44-48. 1987
  • Reduction in bleomycin-induced lung hydroxyproline content by an iron chelating agent..  89:123S-125S. 1986
  • Bilateral hilar enlargement and hypoperfusion of the right lower lobe.  90:120-121. 1986
  • Coronary artery cardiomyopathy. Hemodynamic and prognostic implications.  89:352-356. 1986
  • Giant cell carcinoma of the lung. Clinical and roentgenographic manifestations.  89:366-369. 1986
  • Potential value of digital radiography. Preliminary observations on the use of dual-energy subtraction in the evaluation of pulmonary nodules.  89:249S-252S. 1986
  • Reduction in bleomycin-induced lung hydroxyproline content by an iron chelating agent.  89:123S-125S. 1986
  • Preventive treatment of tuberculosis..  87. 1985
  • Left ventricular dilatation. Prognostic value in severe left ventricular dysfunction secondary to coronary artery disease.  88:215-220. 1985
  • Primary coronary artery dissection.  87:227-228. 1985
  • Pulmonary hypertension in the interstitial lung diseases.  87:558-560. 1985
  • Smoking cessation.  88:322-324. 1985
  • Resting kinetics of thallium-201 in patients with coronary artery disease.  86:213-218. 1984
  • Lung repair and granuloma formation. Tubercle bacilli stimulated neutrophils release chemotactic factors for monocytes..  83:95S-96S. 1983
  • Current therapy of pulmonary and disseminated fungal diseases.  83:911-917. 1983
  • Effect of oral disopyramide therapy on left ventricular function.  83:480-484. 1983
  • Lung repair and granuloma formation. Tubercle bacilli stimulated neutrophils release chemotactic factors for monocytes.  83:95S-96S. 1983
  • Lupus pleuritis. Clinical features and pleural fluid characteristics with special reference to pleural fluid antinuclear antibodies.  84:714-718. 1983
  • The pleuropulmonary manifestations of the postcardiac injury syndrome.  84:383-387. 1983
  • Treatment of atypical mycobacterial disease.  84:625-628. 1983
  • Ultrastructural subtypes of pulmonary adenocarcinoma. A correlation with patient survival.  84:581-586. 1983
  • Changes in pulmonary blood volume during upright exercise. Clinical implications.  82:54-58. 1982
  • Exercise thallium 201 scintigraphy in evaluating aortocoronary bypass surgery.  80:11-15. 1981
  • Spasm of a saphenous vein bypass graft. A possible mechanism for occlusion of the venous graft.  80:413-415. 1981
  • Changes in intrapulmonary shunting with administration of 100% oxygen.  77:138-141. 1980
  • Coronary angiography soon after myocardial infarction.  77:58-64. 1980
  • Exercise myocardial scintigraphy with 201thallium. Use in patients with mitral valve prolapse without associated coronary artery disease.  77:47-52. 1980
  • Prevalence of mural thrombi and systemic embolization with left ventricular aneurysm. Effect of anticoagulation therapy.  77:463-469. 1980
  • Real time two-dimensional echocardiography in the diagnosis of left atrial myxoma.  78:788-791. 1980
  • Chronotropic and dromotropic effects of histamine on the canine heart.  75:597-604. 1979
  • Duration of action of isosorbide dinitrate.  75:2-4. 1979
  • Deep venous thrombosis of the upper extremity associated with use of the Swan-Ganz catheter.  73:673-675. 1978
  • Pulmonary consolidation associated with infusion of a glucose insulin potassium solution in acute myocardial infarction.  73:179-182. 1978
  • Tuberculosis and alcoholism. A partial solution through detection.  73:183-185. 1978
  • Both direct and neurally mediated components of the chronotropic actions of aminophylline.  70:24-32. 1976
  • Direct and vagally mediated chronotropic effects of morphine studied by selective perfusion of the sinus node of awake dogs.  68:222-228. 1975
  • Echocardiography in chronic rheumatic mitral valve disease.  68:569-572. 1975
  • Morphine and autonomic control of the sinus node.  64:203-212. 1973
  • Pulmonary cavitary lesion with productive cough.  64:109-110. 1973
  • International Standard Serial Number (issn)

  • 0012-3692
  • Electronic International Standard Serial Number (eissn)

  • 1931-3543